ReproCELL, Last Fiscal Year Ordinary Profit Turns to Profit, Exceeds Expectations

About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.

Mon May 12, 2025 3:30 pm JST Revision

4978 ReproCELL Incorporated 【J-GAAP】

Guidance Update Report

ReproCELL Incorporated <4978> [TSE Growth] announced a performance revision after the market closed on May 12th (15:30). The consolidated ordinary profit for the fiscal year ending March 2025 has been revised upward from an expected loss of 174 million yen to a profit of 62 million yen (compared to a profit of 40 million yen in the previous period), turning to a profit and leading to a 55.0% increase in the consolidated ordinary profit outlook.

Based on the upwardly revised full-year plan announced by the company, our calculation indicates that the October to March period (2H) consolidated ordinary profit has been revised upward from an expected loss of 71 million yen to a profit of 165 million yen (compared to a loss of 30 million yen in the same period of the previous year), turning to a profit.

Kabutan News

Guidance Update

Second Half Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2024 Prev	1,341	-176	-71	-70	-0.7	0	Nov 13, 2024	J-GAAP
Oct - Mar, 2024 New	1,658	36	165	224	2.4	0	May 12, 2025	J-GAAP
Revision Rate	+23.6%	－	－	－	－

Full Year Update

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2025 Prev	2,661	-325	-174	-174	-1.8	0	May 13, 2024	J-GAAP
Mar, 2025 New	2,978	-113	62	120	1.3	0	May 12, 2025	J-GAAP
Revision Rate	+11.9%	+65.2%	－	－	－

Current Period Guidance

Second Half Results

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Oct - Mar, 2023	1,279	-168	-30	-91	-1.1	0	May 13, 2024	J-GAAP
Oct - Mar, 2024 Guidance	1,658	36	165	224	2.4	0	May 12, 2025	J-GAAP
YoY	+29.6%	－	－	－	－

Current Period Guidance

Fiscal Year	Revenue	Operating Profit	Ordinary Profit	Net Profit	Adj. EPS	Adj. Dividend	Announce	Accounting Standards
Mar, 2023	2,953	-356	-119	-305	-3.6	0	May 12, 2023	J-GAAP
Mar, 2024	2,426	-409	40	-31	-0.4	0	May 13, 2024	J-GAAP
Mar, 2025 Guidance	2,978	-113	62	120	1.3	0	May 12, 2025	J-GAAP
YoY	+22.8%	+72.4%	+55.0%	－	－